Regencell Bioscience Holdings (RGC) Total Debt Growth (1y) (2021)

Regencell Bioscience Holdings (RGC) Total Debt Growth (1y) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -11.90%
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -0.14%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 37.52%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -2.81%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -9.53%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -13.33%
10 Regencell Bioscience Holdings 2.86 Bn 2.86 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -85.93%